FEVER
description
Transcript of FEVER
![Page 1: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/1.jpg)
FEVER
DENGUE VIRUS: NO ONE IS SAFE
Prepared by: Mohamed Abdul Gader
![Page 2: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/2.jpg)
Alternative Names
• West Nile Fever
• Break Bone Fever
• Dengue like Disease
• Onyong- Nyang Fever
![Page 3: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/3.jpg)
WHAT IS DENGUE ?
• Dengue is an arthropod-borne disease caused by any one of four closely related viruses.
• Infection with one serotype of dengue virus provides immunity to that serotype for life.
• A person can be infected as many as four times, once with each serotype.
Holly R. Hughes 2009
![Page 4: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/4.jpg)
DENGUE (cont’d)
• Dengue virus (DEN) is a member of the Flavivirus genus in the Flaviviridae family of single-stranded, positive-polarity, enveloped RNA viruses.
• Dengue viruses are transmitted from person to person by Aedes mosquitoes (most often Aedes aegypti) in the domestic environment.
Burke, D. S., and T. P. Monath. 2001.
![Page 5: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/5.jpg)
Dengue Virus
Electron Micrograms
![Page 6: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/6.jpg)
• About 50–100 million cases of dengue fever and 500,000 cases of Dengue Hemorrhagic Fever (DHF), resulting in around 24,000 deaths, are reported annually.
• dengue is often found in urban areas of tropical nations, including Puerto Rico, Singapore, Malaysia, Taiwan, Thailand, Indonesia, Philippines, Pakistan, India, Brazil, Vietnam, Guyana, Venezuela, Bangladesh.
www.plosone.org 2008
![Page 7: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/7.jpg)
• Dengue’s vectors are two types of Aedes mosquitoes; Aedes aegypti and Aedes albopictus. However, it is the Aedes aegypti species that is most notorious for transmitting dengue.
http://www.cdc.gov
![Page 8: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/8.jpg)
1. Mosquitoes transmitdengue to human dendriticcells
2. Dengue targets areaswith high WBC counts(liver, spleen, lymph nodes, bone marrow, andglands)
3. Dengue enters
WBCs & lymphatic
tissue
4. Dengue enters bloodcirculation
3
4
1
2
3
HOW DENGUE SPREADS
![Page 9: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/9.jpg)
Transmission of Dengue Virus by Aedes aegypti
http://www.cdc.gov
![Page 10: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/10.jpg)
DENGUE (cont’d)
Three Manifestations:1. Dengue Fever2. Dengue Hemorrhagic Fever3. Dengue Shock Syndrome
Leads to death in 5% of cases
More dangerous if infected second time by different serotype
![Page 11: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/11.jpg)
Dengue Fever
• Dengue Fever is an acute febrile illness of 2-7 days duration (sometimes with two peaks) with two or
more of the following manifestations:• Headache retro -orbital pain• myalgia/arthralgia rash• haemorrhagic manifestation (petechiae and positive
tourniquet test) .• leukopenia
![Page 12: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/12.jpg)
Dengue Hemorrhagic Fever (DHF)
A severe form of Dengueresulting from a secondinfection of a different serotype of the virus
First serotype … Dengue fever … Recovery
Second serotype … Risk of DHF
![Page 13: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/13.jpg)
http://www.cdc.gov/ncidod/dvbid/dengue/slideset/set1/images/petechiae2-small.jpg
P E T E C H I A E
![Page 14: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/14.jpg)
P U R P U R A
http://www.pediatrics.wisc.edu/education/derm/tutb/85m.jpg
![Page 15: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/15.jpg)
http://www-medlib.med.utah.edu/WebPath/ATHHTML/ATH036.html
E C C H Y M O S I S
![Page 16: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/16.jpg)
http://www.cgste.mq/brainstorm/dengue/image/hemo.gif
NASAL HEMORRHAGING
![Page 17: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/17.jpg)
Dengue Shock Syndrome
• Dengue Shock Syndrome (DSS) All the above
criteria of DHF plus signs of circulatory failure manifested by rapid and weak pulse, narrow pulse
pressure, hypotension for age, cold and clammy skin
and restlessness
![Page 18: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/18.jpg)
IMMUNE RESPONSE
Stephenson, 2005
![Page 19: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/19.jpg)
FIRST INFECTION
Humoral and cellular immune response
- Ab serum neutralizing levels increase
- T-lymphocytes activated by dendritic cells
- Memory cells develop antibodies to fight off future infection of same serotype
Stephenson, 2005
![Page 20: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/20.jpg)
SECOND INFECTION
Antibody dependent enhancement
- Enhancing immunoglobulin G (IgG) antibodies
- Fc Receptors
Stephenson, 2005
![Page 21: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/21.jpg)
IMMUNO PATHOGENECITY
• Dengue viruses replicate within the cytoplasm of infected cells after receptor-mediated entry
• The known sites of viral replication in vivo are leukocytes, especially circulating B cells, Kupffer cells, and tissue macrophages outside of the neuroaxis
• Infection of dendritic cells by dengue viruses may play an important role in disease pathogenesis
Magill, 2005
![Page 22: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/22.jpg)
Continue …..
• Infection with one dengue virus type appears to confer lifelong homologous immunity but little to no heterologous immunity
• Complement is activated, generating vasoactive cleavage products C3a and C5a. Immune activation and the resulting cytokine and complement cascade appear to account for the plasma leakage and hemostatic defects that occur in DHF
Magill, 2005
![Page 23: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/23.jpg)
Hypothesis on Pathogenesis of DHF -DSS
Persons who have experienced a dengue infection develop serum antibodies that can neutralize the dengue virus of that same (homologous) serotype
![Page 24: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/24.jpg)
Homologous Antibodies Form- Non Infectious Complexes
![Page 25: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/25.jpg)
In a subsequent infection, the pre-existing heterologous antibodies form complexes with the new infecting virus serotype, but do not neutralize the new virus.
Hypothesis on Pathogenesis of DHF-DSS
![Page 26: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/26.jpg)
Heterologous Antibodies Form Infectious Complexes
![Page 27: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/27.jpg)
Antibody-dependent enhancement is the process in which certain strains of dengue virus, complexed with non-neutralizing antibodies, can enter a greater proportion of cells of the mononuclear lineage, thus increasing virus production.
Hypothesis on Pathogenesis of DHF-DSS
![Page 28: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/28.jpg)
Heterologous Complexes Enter More Monocytes, Where Virus Replicates
![Page 29: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/29.jpg)
Infected monocytes release vasoactive mediators, resulting in increased vascular permeability and hemorrhagic manifestations that characterize DHF and DSS.
Hypothesis on Pathogenesis of DHF-DSS
![Page 30: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/30.jpg)
Immunopathogenic Cascade of DHF/DSS
• Macrophage – monocyte infection • Previous infection with heterologous Dengue
serotype results in production of non protective antiviral antibodies
• These Ab bind to the virion’s surface Fc receptor and focus the Dengue virus on to the target cells – macro/monocytes
• T cell - cytokines, interferon, TNF alpha
![Page 31: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/31.jpg)
• (Libraty, D.H., et al. 2004) Elevations of circulating levels of activation markers including soluble TNF receptors, soluble IL-2 receptors, and soluble CD8 have been shown to correlate with disease severity.
http://www.jci.org 2004
![Page 32: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/32.jpg)
• (Jamuna vadivelue 2007) Cytotoxic T lymphocytes (CTL) play an important role in the elimination of dengue virus-infected cells. Identification of antigenic peptides recognized by dengue virus-specific CTL may suggest new ways to suppress viral replication and prevent persistent infection
Jamuna vadivelue 2007
![Page 33: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/33.jpg)
• (Chen ST, Lin YL 2008) Dr. Yi-Ling Lin in the Institute of Biomedical Sciences found that dengue virus binds to a human macrophage surface lectin receptor called CLEC5A and stimulates proinflammatory cytokines release.
Lin YL 2008
![Page 34: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/34.jpg)
Diagnosis
• Isolation of dengue virus• Increased IgM or IgG antibody titer• Dengue antigen detection by immunohistochemistry,
immunofluroscence, ELISA• PCR• leucopenia,thrompocytopenia
![Page 35: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/35.jpg)
Treatment of DF
• No antiviral agents are of proven value• Supportive measures - Vector barrier• Avoid Aspirin and Steroids should not be used• Fluid replacement to avoid hemoconc.• Children below 12 require careful watch
for DHF / DSS
![Page 36: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/36.jpg)
DHF / DSS
Intensive Care
Oxygen
Rehydration
Barrier Nursing
Mosquito Screen
Blood or platelet Transfusions
![Page 37: FEVER](https://reader035.fdocuments.us/reader035/viewer/2022062520/5681582b550346895dc590d6/html5/thumbnails/37.jpg)
Thank Youfor Your Attention